RENAL CANCER RECURRENT

RENAL CANCER RECURRENT was reported 147 times

These drug classes are most commonly taken by patients reporting RENAL CANCER RECURRENT:

# Drug Count
0 Programmed Death Receptor-1 Blocking Antibody [EPC] 22
1 Kinase Inhibitor [EPC] 19
2 Corticosteroid [EPC] 16
3 Nonsteroidal Anti-inflammatory Drug [EPC] 16
4 Platelet Aggregation Inhibitor [EPC] 9
5 Proton Pump Inhibitor [EPC] 8
6 Opioid Agonist [EPC] 7
7 Sulfonylurea [EPC] 7
8 Tumor Necrosis Factor Blocker [EPC] 7
9 mTOR Inhibitor Immunosuppressant [EPC] 7
10 Folate Analog Metabolic Inhibitor [EPC] 6
11 Vitamin C [EPC] 6
12 Benzodiazepine [EPC] 5
13 GLP-1 Receptor Agonist [EPC] 5
14 Provitamin D2 Compound [EPC] 5
15 beta-Adrenergic Blocker [EPC] 5
16 Angiotensin 2 Receptor Blocker [EPC] 4
17 Aromatase Inhibitor [EPC] 4
18 Calcineurin Inhibitor Immunosuppressant [EPC] 4
19 Integrin Receptor Antagonist [EPC] 4
20 Loop Diuretic [EPC] 4
21 alpha-Adrenergic Blocker [EPC] 4
22 Alkylating Drug [EPC] 3
23 Anti-epileptic Agent [EPC] 3
24 Calcium Channel Blocker [EPC] 3
25 Cytochrome P450 3A Inhibitor [EPC] 3
26 Dihydropyridine Calcium Channel Blocker [EPC] 3
27 Factor Xa Inhibitor [EPC] 3
28 HMG-CoA Reductase Inhibitor [EPC] 3
29 Parathyroid Hormone Analog [EPC] 3
30 Protease Inhibitor [EPC] 3
31 Purine Antimetabolite [EPC] 3
32 Vitamin B12 [EPC] 3
33 Vitamin D [EPC] 3
34 Atypical Antipsychotic [EPC] 2
35 CD20-directed Cytolytic Antibody [EPC] 2
36 Calcium [EPC] 2
37 Chloride Channel Activator [EPC] 2
38 Cholinergic Nicotinic Agonist [EPC] 2
39 Expectorant [EPC] 2
40 Insulin Analog [EPC] 2
41 Interferon beta [EPC] 2
42 Interleukin-23 Antagonist [EPC] 2
43 Interleukin-4 Receptor alpha Antagonist [EPC] 2
44 Janus Kinase Inhibitor [EPC] 2
45 Mood Stabilizer [EPC] 2
46 Platinum-based Drug [EPC] 2
47 Rifamycin Antibacterial [EPC] 2
48 Topoisomerase Inhibitor [EPC] 2
49 5-alpha Reductase Inhibitor [EPC] 1
50 Actinomycin [EPC] 1
51 Alkaloid [EPC] 1
52 Amide Local Anesthetic [EPC] 1
53 Antiarrhythmic [EPC] 1
54 Azole Antifungal [EPC] 1
55 Bispecific CD20-directed CD3 T Cell Engager [EPC] 1
56 CTLA-4-directed Blocking Antibody [EPC] 1
57 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1
58 Epidermal Growth Factor Receptor Antagonist [EPC] 1
59 Erythropoiesis-stimulating Agent [EPC] 1
60 Glinide [EPC] 1
61 Histamine-1 Receptor Antagonist [EPC] 1
62 Human Immunoglobulin G [EPC] 1
63 Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] 1
64 Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] 1
65 Insulin [EPC] 1
66 Interleukin-12 Antagonist [EPC] 1
67 Interleukin-17A Antagonist [EPC] 1
68 Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] 1
69 Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC] 1
70 Nucleoside Metabolic Inhibitor [EPC] 1
71 Osmotic Laxative [EPC] 1
72 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1
73 Peroxisome Proliferator Receptor gamma Agonist [EPC] 1
74 Phosphodiesterase 4 Inhibitor [EPC] 1
75 Phosphodiesterase 5 Inhibitor [EPC] 1
76 Progestin Antagonist [EPC] 1
77 Prostacycline Vasodilator [EPC] 1
78 Prostaglandin E1 Analog [EPC] 1
79 Serotonin-3 Receptor Antagonist [EPC] 1
80 Somatostatin Analog [EPC] 1
81 Thiazide Diuretic [EPC] 1
82 Thiazolidinedione [EPC] 1
83 beta3-Adrenergic Agonist [EPC] 1